🔗 Permalink

Inventor profile of:

Daisuke ASARI

City:

Osaka

Country:

Japan

Published Applications:

Last publication date:

2020-12-03

Top Assignees for applications by Daisuke ASARI

The entities that hold a legal rights for patent applications filed by inventor ASARI Daisuke:

NITTO DENKO CORPORATION 29 Osaka, Japan
OSAKA UNIVERSITY 5 Osaka, Japan
NOTTO DENKO CORPORATION 1 Osaka, Japan

Recent patent applications by ASARI Daisuke

Daisuke ASARI from Osaka, JP has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-12-03

US20200376111A1

Human necessities

VACCINE COMPOSITION

#2 | 2019-10-03

US20190298825A1

Human necessities

Composition for enhancing induction of humoral immunity, and vaccine pharmaceutical composition

#3 | 2019-02-14

US20190046635A1

Human necessities

COMPOSITION FOR IMMUNITY INDUCTION PROMOTION AND VACCINE PHARMACEUTICAL COMPOSITION

#4 | 2018-11-15

US20180326042A1

Human necessities

Dried influenza vaccine preparation and method for producing dried influenza vaccine preparation

#5 | 2018-11-15

US20180326041A1

Human necessities

Vaccine pharmaceutical composition for oral administration and method for manufacturing vaccine pharmaceutical composition for oral administration

#6 | 2018-06-21

US20180169227A1

Human necessities

Immunity induction promoting composition, and vaccine pharmaceutical composition

#7 | 2018-05-31

US20180147235A1

Human necessities

Allergy vaccine composition

#8 | 2017-12-21

US20170360908A1

Human necessities

Vaccine pharmaceutical composition for cell-mediated immunity containing bisphosphonates

#9 | 2017-10-05

US20170281759A1

Human necessities

Bisphosphonate-containing vaccine pharmaceutical composition for humoral immunity

#10 | 2017-08-31

US20170246287A1

Human necessities

VACCINE COMPOSITION FOR TRANSDERMAL ADMINISTRATION

#11 | 2017-08-10

US20170224813A1

Human necessities

VACCINE PHARMACEUTICAL COMPOSITION FOR SUPPRESSING APOPTOSIS OF CTL OR INHIBITING SUPPRESSION OF INDUCTION OF CTL

#12 | 2017-08-10

US20170224812A1

Human necessities

Liquid immunity induction-promoting composition and vaccine pharmaceutical composition that include thrombosis treatment drug

#13 | 2017-08-03

US20170216431A1

Human necessities

Vaccine pharmaceutical composition for transdermal administration

#14 | 2017-08-03

US20170216430A1

Human necessities

IMMUNE-INDUCTION-PROMOTING COMPOSITION INCLUDING NUCLEAR RECEPTOR LIGAND, AND VACCINE PHARMACEUTICAL COMPOSITION

#15 | 2017-08-03

US20170216429A1

Human necessities

Composition for enhancing induction of humoral immunity, and vaccine pharmaceutical composition

#16 | 2017-02-02

US20170028054A1

Human necessities

VACCINE COMPOSITION

#17 | 2016-10-06

US20160287697A1

Human necessities

Injectable vaccine composition

#18 | 2016-08-11

US20160228540A1

Human necessities

Nasal mucosal vaccine composition

#19 | 2016-07-28

US20160213773A1

Human necessities

Mucosal vaccine composition

#20 | 2016-07-21

US20160206728A1

Human necessities

DRIED INFLUENZA VACCINE PREPARATION AND METHOD OF PRODUCING THE SAME

#21 | 2016-07-07

US20160193327A1

Human necessities

Mucosal vaccine composition

#22 | 2014-08-21

US20140234377A1

Human necessities

VACCINE COMPOSITION FOR MUCOSAL ADMINISTRATION

#23 | 2014-08-07

US20140220105A1

Human necessities

Tape preparation of WT1 peptide cancer vaccine for transdermal administration

#24 | 2014-08-07

US20140220100A1

Human necessities

VACCINE COMPOSITION FOR TRANSDERMAL ADMINISTRATION

#25 | 2014-08-07

US20140220079A1

Human necessities

VACCINE COMPOSITION FOR MUCOSAL ADMINISTRATION

#26 | 2014-08-07

US20140220063A1

Human necessities

Vaccine composition

#27 | 2014-08-07

US20140220059A1

Human necessities

WT1 peptide cancer vaccine composition for mucosal administration

#28 | 2014-08-07

US20140220058A1

Human necessities

VACCINE COMPOSITION FOR TRANSDERMAL OR MUCOSAL ADMINISTRATION

#29 | 2014-08-07

US20140220057A1

Human necessities

WT1 peptide cancer vaccine composition for transdermal administration

#30 | 2014-08-07

US20140220056A1

Human necessities

VACCINE COMPOSITION FOR TRANSDERMAL ADMINISTRATION

#31 | 2014-08-07

US20140220055A1

Human necessities

WT1 peptide cancer vaccine composition for transdermal administration

#32 | 2013-10-10

US20130266612A1

Human necessities

Vaccine composition

#33 | 2013-07-11

US20130177594A1

Human necessities

PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING THE SAME

#34 | 2012-11-22

US20120294894A1

Human necessities

PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING THE SAME

InventorID:

334224 ⎘